COSCIENS Biopharma (CSCIF) Stock Statistics & Valuation Metrics

COSCIENS Biopharma has a market cap or net worth of $6.41M. The enterprise value is -$24.22M.

COSCIENS Biopharma has 3,183,455 shares outstanding. The number of shares has decreased by -2.65% in one year.

COSCIENS Biopharma’s return on equity (ROE) is -0.20 and return on invested capital (ROIC) is -49.62%.

The current PE Ratio of COSCIENS Biopharma is ―. COSCIENS Biopharma’s PEG ratio is 0.00.

In the last 12 months, COSCIENS Biopharma had revenue of 4.50M and earned -3.55M in profits. Earnings per share was -1.92.

In the last 12 months, operating cash flow was -14.44M and capital expenditures -176.00K, giving a free cash flow of -14.62M billion.

COSCIENS Biopharma pays an annual dividend of ―, resulting in a dividend yield of ―

COSCIENS Biopharma upcoming earnings date is Apr 15, 2026, After Close (Confirmed).

COSCIENS Biopharma as a current ratio of ―, with Debt / Equity ratio of 18.63%

In the past 12 months, COSCIENS Biopharma has paid -1.47M in taxes.

COSCIENS Biopharma EV to EBITDA ratio is -1.07, with an EV/FCF ratio of -1.13.

COSCIENS Biopharma has $27.80M in cash and marketable securities with $1.69M in debt, giving a net cash position of $26.12M billion.

Gross margin is 95.06%, with operating margin of ―, and net profit margin of ―.

The average price target for COSCIENS Biopharma is ―, which is 11.43% higher than the current price. The consensus rating is ―